New Delhi: The Indian biotech companies are actively developing mRNA-based vaccines and therapeutics, said a team of scientists at the Department of Biotechnology (DBT), under the Ministry of Science and Technology.
They were speaking at the 14th Webinar under the ‘Webinar Series on Biofoundry and Biomanufacturing Initiative’, along with Biotechnology Industry Research Assistance Council (BIRAC).
The session focused on “Biomanufacturing for mRNA Therapeutics”, a vital component under the BioE3 (Biotechnology for Economy, Environment and Employment) Policy.
“The BioE3 Policy’s vision is to foster high-performance biomanufacturing by supporting sustainable green growth. This approach marks a global shift toward sustainability, fuelling a ‘BioRevolution’ with the potential to reshape economies and societies,” said Dr. Alka Sharma, Senior Adviser/Sc ‘H’, DBT.
She also informed that the 14th Webinar in this series focuses on mRNA therapeutics, a key thematic subsector under the policy.
“Several Indian biotech companies and research institutions are actively involved in developing mRNA-based vaccines and therapeutics,” Sharma said, while also highlighting certain challenges plaguing the sector such as product delivery, product stability, and import dependence for raw materials.
Approved by the Union Cabinet and released by the Minister of Science and Technology, the BioE3 Policy aims to position India as a global leader in bio-based innovations.
It focuses on promoting sustainable biomanufacturing in diverse thematic areas including Precision Therapeutics such as mRNA therapeutics, supporting economic growth while promoting affordable healthcare accessible to the Indian population.
Dr. Varshneya Singh, Scientist ‘D’, DBT, provided an insightful overview of the mRNA therapeutics subsector.
“mRNA-based therapies represent a groundbreaking advancement in biotechnology, with the potential to tackle a broad spectrum of diseases, including cancer, genetic conditions, and infectious diseases,” Singh said.
He provided a SWOT analysis of the subsector, identifying its strengths, weaknesses, opportunities, and threats.
Dr. Raghavan Varadarajan, IISc Bangalore explored cutting-edge advances in mRNA-LNP vaccine technology, emphasising its revolutionary role in modern medicine.
He talked about the mRNA vaccine design workflow; major advantages of mRNA vaccine modality; key structural elements of mRNA; workflow for LNP preparation, comparative analysis of different mRNA-LNP formulations, different kinds of microfluidic chips used, and comparison of different formulation methods.
The Webinar served as a collaborative forum, bringing together academia, industry experts, start-ups, and researchers to explore the latest developments and emerging opportunities in the field of mRNA therapeutics biomanufacturing.
IANS
India successfully tests indigenous UAV ‘Rudrastra’ in Jaisalmer
Jaipur: India has taken a significant leap in defence technology with the successful test of Rudrastra, an indigenous hybrid vertical takeoff and landing (VTOL) unmanned aerial vehicle (UAV), developed by...
South Korean firms invest record $61.1 billion in R&D in 2024
Seoul: South Korean companies spent a record amount of 83.6 trillion won ($61.1 billion) on research and development (R&D) projects last year as part of efforts to enhance their competitiveness...
DRDO transfers 9 technologies to industrial firms for production of defence vehicles
New Delhi: In line with the government’s vision to establish a robust defence industrial ecosystem with the participation of both public and private sectors, the Vehicles Research & Development Establishment...
Samsung to adopt AI coding assistant to boost developer productivity
Seoul: Samsung Electronics said on Sunday it will adopt an artificial intelligence (AI) coding assistant service called Cline next month to enhance productivity among its software development employees. In a...
Nano urea revolutionised agriculture sector slashing chemical fertiliser use: Mansukh Mandaviya
New Delhi: Nano urea, based on nanotechnology, has revolutionised the agriculture sector, and has slashed the use of chemical fertilisers that are harmful to soil and health, Union Minister of...
Australian scientists introduce real-time genome sequencing to combat deadly superbug
Sydney :Australian researchers have achieved a major advance in tackling Staphylococcus aureus, commonly known as golden staph, a superbug that causes more than a million deaths worldwide each year. The...
AIIMS Delhi, IIT Delhi to establish Center of Excellence for AI in healthcare
New Delhi: The All-India Institute of Medical Sciences (AIIMS) on Wednesday announced signing a partnership agreement with the Indian Institute of Technology (IIT) Delhi to establish a Center of Excellence...
Microsoft lays off more employees after huge job cut in AI era
New Delhi: Tech giant Microsoft has cut hundreds of more jobs just weeks after reducing nearly 3 per cent of its global workforce in the AI era. As per a...
IIT Kharagpur launches India’s 1st academic accelerated pavement test facility
New Delhi: The Indian Institute of Technology (IIT) Kharagpur has launched India’s first Accelerated Pavement Testing Facility (K-APTF), marking a significant leap in indigenous research and development in road infrastructure....
India’s AI ecosystem on the cusp of global breakthrough: Ashwini Vaishnaw
New Delhi: India's artificial intelligence (AI) ecosystem is now on the cusp of a global breakthrough, Union Minister of Electronics and IT, Ashwini Vaishnaw, has said. Opportunity given by the...
India’s fintech lenders draw younger, more rural customer base: Report
Mumbai: The fintech sector lenders are drawing a younger and more rural customer base, with 61 per cent of borrowers being under the age of 30, and 24 per cent...
Low-carbon tech key to achieving ‘Net Zero 2070’ target: Dr Jitendra Singh
New Delhi: A robust ecosystem will help India propel towards becoming the world’s third-largest economy, while low-carbon technologies will be key to achieving ‘Net Zero 2070’ target, Union Minister Dr...
